Discovering CBD

In 1940, American Chemist Roger Adams made history when he isolated the first cannabinoid called Cannabidiol (CBD) from marijuana. His research also led him to discover Tetrahydrocannabinol (THC). Most people give this credit to Dr. Raphael Mechoulam but it was Adams who deserves the credit. Although he separated both CBD and THC, scientist say he did not really know what he had found. It wasn’t until 1946 when Dr. Walter Loewe began testing these cannabinoids on lab animals, but he was unable to identify which compound was responsible for which reaction.

CBD Breakthrough

Dr. Raphael Mechoulam is considered the father of cannabis because he was the first to discover the effects of individual cannabinoids in 1963. Although Adams first isolated CBD and THC he could not define these cannabinoids chemical structure. That credit goes to Israeli scientist, Dr. Raphael Mechoulam. Without his discoveries we would not know that THC is the psychoactive compound in marijuana and that CBD is non intoxicating. After this discovery was made it did not take long for interest in the plants potential medicinal value began to be explored. The first full spectrum CBD oil was released by the mid 70’s.

Advancements in research did not translate to Americans. CBD was unknown and classified as a drug just as marijuana. In 1970, President Richard Nixon signed the Controlled Substance Act as part of the War on Drugs initiative. This placed marijuana on the list as a Schedule I drug along with heroin and LSD. This classification alone, determined that cannabis had no medical benefits and had a high potential for abuse. It was often called a “gateway drug” to more severe drugs.

In 1978 the Controlled Substance Therapeutic Research Act passed. This is significant because it legally recognized the medicinal value of cannabis. It did not specifically name CBD but it was a landmark approval in the United States because it represented the first time a cannabis compound as legal for its medicinal potential.

CBD Shows Promise for Epilepse

In the 80’s Dr. Mechoulam and his team of researchers conducted the first study on cannabis and epilepsy. During the first clinical trial, participants (mostly children) with epilepsy were given 300mg of CBD a day. After just four months, everyone of the participants had an improved condition. Half of the subjects stopped having seizures all together and the others had fewer. This was a huge discovery and had the potential to change the lives of anyone with epilepsy. Sadly, the results that could have sparked worldwide use of CBD to help people with seizures was never accepted and never shared with the public. It is believed that the stigma surrounding cannabis kept this discovery from being acknowledged.

“Who cared about our findings? No one! …And that’s despite many of the epilepsy patients being kids who have 20, 30, 40 seizures a day. And what did they do? Nothing!” Dr. Raphael Mechoulam

The lack of reporting and fanfare did not keep the team from progressing. The next major discovery was about ten years later when this team identified the Endocannabinoid system in the 90’s. This is the system within our bodies that contains a network of receptors that interact and respond with cannabinoids. It was also when the therapeutic benefits of other cannabinoids in conjunction with CBD and THC were discovered.

Cannabis becomes legal in California

In 1996, California became the first state to legalize marijuana under the Compassionate Use Act for people with severe or chronic illnesses. The legalization of marijuana in several states slightly opened the availability for researching CBD for the treatment of a variety of conditions such as pain, epilepsy and many neurological diseases. This marked the beginning of acceptance, but it was still a long way away from being mainstream. Because of CBD’s close relationship to marijuana it was often categorized as a drug and judged under the same laws.

Government secures CBD patent

In 2003, the United States government patents CBD as a neuroprotectant under US patent #6,630,507. It was granted to the U.S. Department of Health and Human Services. It reads as follows: Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and HIV dementia. Non-Psychoactive cannabinoids, such as cannabidiol, are particularly advantageous to use because they avoid toxicity that is encountered with psychoactive cannabinoids at high doses useful in the method of the present invention. Although this patent was great news it did not help open the door for access to CBD. In fact, CBD remained on the list as a Schedule I drug, along with narcotics such as LSD and Heroin.

A child’s story paves way for acceptance of CBD

Charlotte Figi was born in 2006 with a rare form of epilepsy called Dravet Syndrome. At the age of four she was suffering with 300 seizures every week. Her parents were desperate for something to help her. Left with no more options they turned to cannabis, hoping for a miracle.

After consuming a small dose of CBD oil, they received the miracle they hoped for. Charlotte’s seizures stopped almost immediately. Today, Charlotte still experiences two to three seizures a month, but she now has an opportunity to live a normal life.

Charlotte’s success story spread like wildfire when other desperate parents hoped CBD would also work for their child. Her story has helped so many just like her and well beyond imagination. Charlotte’s story and success has fueled a movement that is giving others hope when all else fails. It also has provided a level of awareness and confidence in natural alternative medicines that simply has not existed to the level that it exists today and is growing.

Charlotte was the first and her story continues to help people all over the world with seizures and so much more.

Read more about how CBD may help you

CBD Today

Charlotte was the child that brought this plant into focus. Her astonishing results were so amazing that it was impossible to ignore. Since then more and more people are learning about the medicinal powers of CBD. Many are learning that it is not a drug but a powerful extract that is helping people with so many ailments, conditions and diseases. People that turned their noses up to cannabis at one point are now informed and often taking it for pain, inflammation, sleep, stress, anxiety and so much more.

At CBD BioCare we identify the CBD revolution as a movement that is changing lives, one bottle at a time. CBD has made massive strides over the past few years, but we are still in the early stages. Due to the millions of success stories that can now be read and watched on every medium available, CBD can no longer be dismissed or ignored. It is here to stay.

Already this industry has helped millions of people, not to mention generated billions of dollars. Research is being approved and revealing even more evidence of therapeutic and medicinal benefits. Hemp is legal under the 2018 Farm Bill and CBD products are being sold online and in retailers across the country.

Although this industry has come a long way, there is still much work to be done. We are happy you landed on this website so that we can inform you and help you make an educated buying decision.